Kuehne + Nagel invests in a pharma logistics facility in Switzerland


Kuehne + Nagel has announced that it is investing in the construction of a large-scale pharma logistics facility in Möhlin, Switzerland. The pharma hub will be part of the KN PharmaChain network, providing multimodal temperature-controlled door-to-door shipping on a global scale, enhanced visibility and traceability of the deliveries, as well as proactive risk management. 

The new Kuehne + Nagel logistics facility will provide 16,300 sq m of logistics space, which will be used to manage approximately 46,000 pallet spaces using a warehouse system that combines manual and automatic operation. Three different temperature zones will be available for the highly sensitive products: -20 degrees, -2 to +8 degrees, plus +15 to +25 degrees. In addition, hazardous goods and narcotics can be stored in dedicated areas.

The Möhlin pharma hub will also focus on providing value-added services. The facility will provide end-to-end shipping and logistics services based on GxP-compliant standard. 

Detlef Trefzger, CEO of Kuehne + Nagel International AG, said: “Switzerland is an important pharma location with global reach. The cutting-edge facility in Möhlin is a strategic investment in this growth sector and supports us to serve our customers even better, especially through integration with the global Kuehne + Nagel pharma network.”

Source: Kuehne + Nagel

GSCi

The world's largest collection of global supply chain intelligence

  • quickly and easily search and gain invaluable insight into the logistics industry
  • Empower everyone from business development executives to CEO level
  • Enhance the role of the market research department
Loading...
Loading...